Skip to main content
Publications
Saigi-Morgui N , Rebordosa C , Plana E , Rubino A, Aguado J , Martinez D , Lei A, Daoud SZ, McMahon P, Perez-Gutthann S , Rivero-Ferrer E . Acute myocardial infarction, stroke, and MACE in COPD patients treated with aclidinium and other inhaled bronchodilators . Poster presented at the 2022 ICPE Conference; August 2022. Copenhagen, Denmark.
Garcia de Albeniz X , Polo R, Teran C, Morales M, Rial-Crestelo D, Garcinuno MA, Garcia del Toro M, Hita C, Gomez-Sirvent JL, Buzon L, Diaz de Santiago A, Perez JL, Sanz J, Bachiller P, Martinez E, Diaz-Brito V, Masia M, Hernandez-Torres A, Guerra J, Arazo P, Arribas J, Martinez de Salazar P, Moreno S, Hernan MA, Del Amo J. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workers. A randomized clinical trial . Poster presented at the 2022 ICPE Conference; August 2022. Copenhagen, Denmark.
Perdrizet J, Horn EK, Hayford K, Grant L, Barry R, Huang L, McDade C , Wilson M . Estimating the historical population-level impact of PCV13 national immunization programs on invasive pneumococcal disease in Australia, Canada, Israel, England & Wales, and the United States . Poster presented at the ISPPD-12 (International Society of Pneumonia and Pneumococcal Diseases); June 19, 2022. Toronto, Canada.
Perdrizet J, Horn EK, Hayford K, Grant L, Barry R, Huang L, McDade C , Wilson M . Non-vaccine serotype population-level trends for invasive pneumococcal disease in Australia, Canada, Israel, England & Wales, and the United States . Poster presented at the ISPPD-12 (International Society of Pneumonia and Pneumococcal Diseases); June 19, 2022. Toronto, Canada.
Diez-Campelo M, Yucel A, Goyal R , Parikh R , Dhuliawala S, Jimenez M , Sluga-O'Callaghan M , Hughes C, Tang D, Germing U. Systemic therapy utilization and hematologic outcomes in lower-risk myelodysplastic syndromes (LR-MDS): findings from a real-world medical record review study in the US, UK, and Europe (EU) . Poster presented at the 2022 European Hematology Association Hybrid Congress; June 10, 2022. Vienna, Austria.
Spira A, Liao L, Zhou X , Gnanasakthy A , Chen L, Ungar D, Yu E, Kilavuz T, Radford J, Hamadani M. Health-related quality of life and tolerability of loncastuximab tesirine in high-risk patients with relapsed/refractory diffuse large B-cell lymphoma treated in a phase 2 clinical trial (LOTIS 2) . Poster presented at the 2022 EHA Congress; June 9, 2022. Vienna, Austria.
Lin SH, Ahn M, Nagar S , Affi R, Agulnik J, Shih J, Hochmair MJ, Tufman A, Debieuvre D, Jimenez MI , Davis K , Kahangire DA, Servidio L, Veluswamy R. Treatment patterns and outcomes in resectable early stage NSCLC: interim analysis of a global real-world study . Poster presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting; June 3, 2022. Chicago, IL.
Paller A, Siegfried E, Marron SE, Clark M , Kosa K , Whalley D , Chao J, Bansal A, Chuang CC, Wang Z. Development and validation of a caregiver-reported numeric rating scale for measuring sleep quality in children aged 6 months to 5 years with atopic dermatitis . Poster presented at the 2022 Society for Investigative Dermatology (SID) Annual Meeting; May 2022. Portland, OR.
Paller A, Siegfried E, Marron SE, Clark M , Harris N , Qin S , Chao J, Bansal A, Chuang CC, Wang Z. Development and validation of a caregiver-reported numeric rating scale for measuring skin pain in children (aged 6 months to 5 years) with atopic dermatitis . Poster presented at the 2022 Society for Investigative Dermatology (SID) Annual Meeting; May 2022. Portland, OR.
Boucher N, Van Voorhees E, Vashi A, Dong O , Morgan P, Smith JE, Adam S, Alishahi A, Mulholland MJ, Dietch JR, Whited JD, Boggan JC, Fulton JJ, Cameron CB, Gordon A, Goldstein KM, Ear B, Williams JW, Cantrell S, Dickerson SW, Gierisch JM. Tele-urgent care for low-acuity conditions: a systematic review . 2022.
Spira A, Liao L, Zhou X , Sherif B , Chen L, Ungar D, Yu E, Radford J, Hamadani M. Health-related quality of life, symptoms, and tolerability of Loncastuximab Tesirine in older versus younger patients with relapsed/refractory diffuse large b-cell lymphoma treated in a phase 2 clinical trial (LOTIS-2) . Poster presented at the National Comprehensive Cancer Network (NCCN) 2022 Virtual Annual Conference; March 31, 2022.
Prabhu V, Kelkar S, Corman S, Macahilig C, Rusibamayila N, Odak S , Duska L. Treatment patterns, real-world outcomes, and resource use in patients with non-MSI-high or mismatch repair proficient advanced endometrial cancer . Poster presented at the 2022 Virtual Hem/Onc Pharmacists Assoc (HOPA) Annual Conference; March 30, 2022. Boston, MA.
Osborne R, Nelson L , Fehnel S , Williams N, Bender RH, Ziemiecki R , Gymnopoulou E, De Paepe E, Norcross L , Heijnen E, Ispas G, Cheret A, Comeaux C, Callendret B, Vandendijck Y, Chan E, Scott J. Measurement of symptoms in respiratory syncytial virus–infected adults: meaningful within-patient change thresholds for the respiratory infection intensity and impact questionnaire (RiiQ) . Poster presented at the 8th ESWI Influenza Conference Scientific and SPI Virtual Programme; December 4, 2021.
Walsh J, Myers K , Mansfield C , Tillett W, Nash P, Leach C, Nowell W, Gavigan K, Zueger P, McDearmon-Blondell E, Ogdie-Beatty A. Impact of treatment experience on patient preferences and disease burden in psoriatic arthritis: results from a rheumatology patient research registry . Poster presented at the 2021 Virtual ACR Convergence; November 8, 2021.